SG11201408287RA - Rapid specific pathogen free animal - Google Patents

Rapid specific pathogen free animal

Info

Publication number
SG11201408287RA
SG11201408287RA SG11201408287RA SG11201408287RA SG11201408287RA SG 11201408287R A SG11201408287R A SG 11201408287RA SG 11201408287R A SG11201408287R A SG 11201408287RA SG 11201408287R A SG11201408287R A SG 11201408287RA SG 11201408287R A SG11201408287R A SG 11201408287RA
Authority
SG
Singapore
Prior art keywords
international
specific pathogen
polypeptide
animal
rule
Prior art date
Application number
SG11201408287RA
Inventor
Eng Huan Ung
Bakar Ag Muhammad Sagaf Abu
Original Assignee
Biovalence Sdn Bhd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biovalence Sdn Bhd filed Critical Biovalence Sdn Bhd
Publication of SG11201408287RA publication Critical patent/SG11201408287RA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/033—Rearing or breeding invertebrates; New breeds of invertebrates
    • A01K67/0333—Genetically modified invertebrates, e.g. transgenic, polyploid
    • A01K67/0337—Genetically modified Arthropods
    • A01K67/0338—Genetically modified Crustaceans
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4723—Cationic antimicrobial peptides, e.g. defensins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2497—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing N- glycosyl compounds (3.2.2)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Environmental Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Animal Husbandry (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date 3 January 2014 (03.01.2014) WIPOIPCT (10) International Publication Number WO 2014/003538 A1 (51) International Patent Classification: A01K 67/027 ( 2006.01) C07K19/00 (2006.01) A61K 38/17 (2006.01) C12N15/62 (2006.01) (21) International Application Number: (22) International Filing Date: (25) Filing Language: (26) Publication Language: PCT/MY2013/000116 25 June 2013 (25.06.2013) English English (30) Priority Data: PI2012002924 26 June 2012 (26.06.2012) MY (71) Applicant: BIOVALENCE SDN. BHD. [MY/MY]; 21, Jalan SS25/34, Taman Mayang Industrial Park, Petaling Jaya 47301 (MY). (72) Inventors: UNG, Eng Huan; No. 2, Lorong Ujana King­ fisher 9, Kingfisher Ujana, Kota Kinabalu 88300, Sabah (MY). ABU BAKAR, Ag., Muhammad Sagaf; P.O. Box 81, Pos Mini, Central Plaza, Kota Kinabalu 88300, Sabah (MY). (74) Agents: JEFFREY, Fiona, Teresa et al.; Marks & Clerk (Malaysia) Sdn Bhd, P.O. Box 11182, Kuala Lumpur 50738 (MY). (81) Designated States (unless otherwise indicated, for every kind of national protection available)'. AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (84) Designated States (unless otherwise indicated, for every kind of regional protection available)'. ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG). Declarations under Rule 4.17: — of inventorship (Rule 4.17(iv)) Published: — with international search report (Art. 21(3)) — before the expiration of the time limit for amending the claims and to be republished in the event of receipt of amendments (Rule 48.2(h)) (54) Title: RAPID SPECIFIC PATHOGEN FREE ANIMAL 00 m m o o o CJ o & 10 1) 12 13 14 Control Treated (57) Abstract: A method of producing at least one specific pathogen free (SPF) non-human animal and/or method of producing a at least one specific pathogen resistant (SPR) non-human animal, the method comprising administration of a fusion protein the to sur­ viving animal wherein the fusion protein comprises at least one polypeptide B which is a Type 1 Ribosome Inactivating Protein (RIP) or fragment thereof; and (i) at least one polypeptide A which an Antimicrobial peptide; is and/or (ii) at least one polypeptide C which is a Cationic Antimicrobial Peptide (CAP) or fragment thereof.
SG11201408287RA 2012-06-26 2013-06-25 Rapid specific pathogen free animal SG11201408287RA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
MYPI2012002924 2012-06-26
PCT/MY2013/000116 WO2014003538A1 (en) 2012-06-26 2013-06-25 Rapid specific pathogen free animal

Publications (1)

Publication Number Publication Date
SG11201408287RA true SG11201408287RA (en) 2015-01-29

Family

ID=49783571

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201408287RA SG11201408287RA (en) 2012-06-26 2013-06-25 Rapid specific pathogen free animal

Country Status (4)

Country Link
US (1) US20150173333A1 (en)
CN (1) CN104812241A (en)
SG (1) SG11201408287RA (en)
WO (1) WO2014003538A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103923887A (en) * 2014-04-16 2014-07-16 辽宁医学院 Pseudoviral particle containing hepatitis e virus RNA (Ribose Nucleic Acid) fragment and preparation method thereof
CN103951713A (en) * 2014-05-19 2014-07-30 黑龙江省中医药科学院 Comprehensive utilization method for improving value of cucumis sativus seed medicinal materials
TWI498335B (en) * 2014-06-24 2015-09-01 Univ Nat Cheng Kung Primers, method and use for specific detecting toxin of pathogen of acute hepatopancreatic necrosis disease
ES2952744T3 (en) 2016-12-15 2023-11-03 Nestle Sa Compositions and procedures that modulate white blood cells or neutrophils in a companion animal
CN110776560B (en) * 2019-10-09 2021-02-02 厦门大学 Sparus latus antibacterial peptide AS-hepc3(48-56)And uses thereof
CN112063593B (en) * 2020-09-17 2021-08-31 扬州大学 Pathogenic vibrio phage VyZU 10474 and application thereof
CN114672426B (en) * 2022-04-21 2023-11-10 江苏农林职业技术学院 Saccharomyces cerevisiae engineering bacteria, construction method and application thereof
CN117723761A (en) * 2023-12-19 2024-03-19 湖南农业大学 Breeding method of high-resistance Yangtze river grass carp parents based on background immunity level
CN117660157B (en) * 2024-01-31 2024-04-30 江苏大方生物工程有限公司 Low-temperature storage equipment and method for thalli for culturing vibrio parahaemolyticus phage

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1012256T3 (en) * 1997-01-02 2004-07-12 Viscum Ag Recombinant fusion proteins based on ribosome-inactivating proteins from the mistletoe Viscum album
US20030228654A1 (en) * 2000-05-26 2003-12-11 Kabushiki Kaisha Toyota Chuo Kenkyusho Method for producing antimicrobial protein and fusion protein
JP5506792B2 (en) * 2008-06-25 2014-05-28 ブラーシュ・バイオテック・エルエルシー Chloramphenicol acetyltransferase (CAT) incomplete somatostatin fusion protein and use thereof
CN101357947A (en) * 2008-09-27 2009-02-04 山西康宝生物制品股份有限公司 Preparation and application of tumour vascular targeting agent VEGF*/RIP30fusion toxin
EP2661451B1 (en) * 2011-01-07 2019-10-09 Valiant Biopharma SDN BHD Antimicrobial fusion compounds and uses thereof
CN102250255B (en) * 2011-06-28 2013-03-06 广西南宁众达生物工程有限公司 Genetic engineering protein TAT-VP28-GH capable of resisting white spot syndrome virus (WSSV) as well as preparation and application thereof

Also Published As

Publication number Publication date
US20150173333A1 (en) 2015-06-25
WO2014003538A8 (en) 2014-02-27
CN104812241A (en) 2015-07-29
WO2014003538A1 (en) 2014-01-03

Similar Documents

Publication Publication Date Title
SG11201408287RA (en) Rapid specific pathogen free animal
SG11201807912SA (en) Vaccine against rsv
SG11201408428PA (en) Dosage regime of fusion compounds
SG11201803900UA (en) Process for preparing polyurea microcapsules with improved deposition
SG11201408646VA (en) Dimeric protein with triple mutations
SG11201901206SA (en) Trimer stabilizing hiv envelope protein mutations
SG11201807913XA (en) Stabilized soluble pre-fusion rsv f proteins
SG11201811431VA (en) Multispecific antibodies against cd40 and cd137
SG11201804411TA (en) Human immunodeficiency virus antigens, vectors, compositions, and methods of use thereof
SG11201908326YA (en) Methods of treating neurodegenerative diseases
SG11201809908TA (en) Stabilized glycopeptide antibiotic formulations
SG11201403106SA (en) Anti-phf-tau antibodies and their uses
SG11201805072PA (en) Nicotine powder delivery system
SG11201408095XA (en) Fibroblast growth factor 21 proteins
SG11201408051VA (en) Cho expression system
SG11201407655TA (en) Therapeutic uses of fibroblast growth factor 21 proteins
SG11201408318RA (en) Compositions and methods for transmucosal absorption
SG11201807827VA (en) Process for the preparation of pegylated drug-linkers and intermediates thereof
SG11201809830WA (en) Selective reduction of cysteine-engineered antibodies
SG11201404836QA (en) Long-acting coagulation factors and methods of producing same
SG11201408037SA (en) Humanized anti-trka antibodies with amino acid substitutions
SG11201810078PA (en) Stabilized pre-fusion rsv f proteins
SG11201806623VA (en) Bacteria over-expressing c-di-amp and therapeutic methods
SG11201806393QA (en) Use of gabaa receptor modulators for treatment of itch
SG11201901188VA (en) Metal powder feedstocks for additive manufacturing, and system and methods for producing the same